Dr Rosalind Eggo

Associate Professor


Keppel Street
United Kingdom

I work as an infectious disease modeller in public health epidemiology. I received my PhD in infectious disease modelling from Imperial College London, and worked at The University of Texas at Austin, before joining the School in May 2015.

My general research interests are in the role of population heterogeneity in epidemics, and vaccination planning and evaluation. I work on influenza, respiratory viruses, Ebola virus disease, zika, and theoretical aspects of disease transmission and control. 

Since the start of the COVID-19 pandemic, I have worked extensively on interventions and response for epidemics in the UK and internationally.

As well as research, I enjoy communicating science to people, and have participated in many outreach activities, such as contributing to the Royal Institution Christmas Lectures in 2019, doing a talk at TEDxThessaloniki in 2018 (video here), and other sorts of activities (Let's play video, RI Apocalypse event, Web App for modelling).


Department of Infectious Disease Epidemiology
Faculty of Epidemiology and Population Health


Centre for the Mathematical Modelling of Infectious Diseases (CMMID)
Vaccine Centre


I've completed LSHTM teaching qualificaitions and  am an Associate Fellow of the HEA. At LSHTM, I teach on modelling short courses, face-to-face modules, and on distance learning courses in mathematical modelling.

I am one of three short-course organisers of a new 3-day short course in modelling in R:

I supervise MSc student summer projects in modelling, usually from MSc Epidemiology, but also CID, and Med Stats.

I also supervise 3 excellent PhD students. Please contact me if you are looking to do a PhD in modelling.


My work involves studying how infectious diseases spread between individuals, and how to design efficient vaccination strategies to mitigate outbreaks and epidemics.

In 2018 I received an HDR UK Innovation Fellowship, to study the dynamics of respiratory viruses and the impact on those with chronic lung diseases like asthma and COPD.

Since the start of the COVID-19 pandemic, I have worked extensively on understanding transmission dynamics, and in the design of interventions and responses for epidemics in the UK and internationally.

I am part of the OpenSAFELY consortium to harness NHS data for COVID-19 response in the UK.

I also study the transmission of Ebola virus disease, especially examining recent outbreaks such as in West Africa and DRC. I develop models that can help determine optimal vaccination deployment schemes in the event of a new EVD outbreak, as well as methods for assessing new vaccines during outbreaks. 

Research Area
Clinical trials
Health care policy
Infectious disease policy
Public health
Bayesian Analysis
Disease control
Global Health
Mathematical modelling
Disease and Health Conditions
Infectious disease
Pandemic diseases
Emerging Infectious Disease
Respiratory disease
Zoonotic disease

Selected Publications

Association between mobility, non-pharmaceutical interventions, and COVID-19 transmission in Ghana: a modelling study using mobile phone data.
Gibbs H; Liu Y; Abbott S; Baffoe-Nyarko I; Laryea DO; Akyereko E; Kuma-Aboagye P; Asante I; Mitjà O; LSHTM CMMID COVID-19 working group
Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: a cohort study using OpenSAFELY
Hulme W; Williamson E; Green A; Bhaskaran K; McDonald H; Rentsch C; Schultze A; Tazare J; Curtis H; Walker A
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic.
OpenSAFELY Collaborative; Curtis HJ; MacKenna B; Walker AJ; Croker R; Mehrkar A; Morton C; Bacon S; Hickman G; Inglesby P
Open heart
Vaccine Confidence and Hesitancy at the Start of COVID-19 Vaccine Deployment in the UK: An Embedded Mixed-Methods Study
Roberts CH; Brindle H; Rogers NT; Eggo RM; Enria L; Lees S
Frontiers in public health
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELY
The OpenSAFELY Collaborative:; Green A; Curtis H; Hulme W; Williamson E; McDonald H; Bhaskaran K; Rentsch C; Schultze A; MacKenna B
Transmission dynamics of SARS-CoV-2 in a strictly-Orthodox Jewish community in the UK
Waites W; Pearson CAB; Gaskell KM; House T; Pellis L; Johnson M; Gould V; Hunt A; Stone NRH; Kasstan B
medRxiv preprint
Evidence for Influenza and RSV interaction from 10 years of enhanced surveillance in Nha Trang, Vietnam, a modelling study
Waterlow N; Toizumi M; van Leeuwen E; Nguyen H-AT; Myint-Yoshida L; Eggo R; Flasche S
How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology.
Waterlow NR; van Leeuwen E; Davies NG; CMMID COVID-19 Working Group; Flasche S; Eggo RM
Proceedings of the National Academy of Sciences of the United States of America
See more Publications